Perspective Therapeutics earnings were -$63.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CATX earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$15.1M, up 29.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CATX reported annual earnings of -$46.5M, with 539.5% growth.
Perspective Therapeutics Earnings Reports & History FAQ
What were Perspective Therapeutics's earnings last quarter?
Perspective Therapeutics (NYSEMKT: CATX) reported Q3 2024 earnings per share (EPS) of -$0.21, up 43.24% year over year. Total CATX earnings for the quarter were -$15.12 million. In the same quarter last year, Perspective Therapeutics's earnings per share (EPS) was -$0.37.
Is Perspective Therapeutics profitable or losing money?
As of the last Perspective Therapeutics earnings report, Perspective Therapeutics is currently losing money. Perspective Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$63.79 million, a 154.12% increase year over year.
What was CATX's earnings growth in the past year?
As of Perspective Therapeutics's earnings date in Q1 2025, Perspective Therapeutics's earnings has grown year over year. CATX earnings in the past year totalled -$63.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.